Amanta Healthcare Q1 Results: Earnings call scheduled for Aug 6

1 min read     Updated on 03 Aug 2026, 11:59 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Amanta Healthcare Limited announced an earnings call for August 6, 2026, to review Q1FY27 performance. The session, hosted by Go India Advisors, features Managing Director Bhavesh Patel and CFO Paras Mehta. Investors must pre-register to join the conference.

powered bylight_fuzz_icon
47284178

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare Limited will host an earnings conference call on Thursday, August 6, 2026, at 11:00 AM IST to discuss its financial performance and business updates for the quarter ended June 30, 2026. The event provides investors with direct access to management insights regarding the company's operational progress during Q1FY27. This disclosure ensures transparency and allows stakeholders to evaluate the firm’s strategic direction ahead of further market movements.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Amanta Healthcare submitted the intimation to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) on August 3, 2026. The filing confirms that the company is adhering to mandatory listing obligations for timely investor communication.

Conference Call Details

The earnings call will be hosted by Go India Advisors. Participants are required to pre-register via the provided link to receive login credentials. The dial-in numbers for the event are +91 22 6280 1557 and +91 22 7115 8383.

Detail Information
Date August 6, 2026
Time 11:00 AM IST
Host Go India Advisors
Quarter Covered Q1 ended June 30, 2026
Registration Mandatory pre-registration required

Management Participation

Key executives from Amanta Healthcare will participate in the discussion to address investor queries. The lineup includes senior leadership responsible for strategic oversight and financial reporting.

  • Bhavesh Patel, Managing Director & Chairman
  • Paras Mehta, Chief Financial Officer
  • Nikhita Dinodia, Company Secretary & Compliance Officer
  • Chintan Pandit, Senior Manager – Finance & Accounts

For further assistance regarding registration or technical support, investors may contact Sheetal Khanduja, Soumya Chhajed, or Shrutee Barve at Go India Advisors.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.97%+5.55%+6.86%+67.35%+21.38%+21.38%

How might Amanta Healthcare's Q1FY27 revenue and margin performance influence its valuation relative to other mid-cap pharmaceutical peers in the upcoming quarter?

What specific strategic initiatives or R&D pipeline updates is management likely to highlight to justify future growth trajectories beyond the current quarter?

Could the operational progress discussed in the call signal any impending changes in dividend policy or capital allocation strategies for FY27?

Amanta Healthcare concludes investor meeting with ValPro Capital

0 min read     Updated on 09 Jul 2026, 08:06 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Amanta Healthcare officials held a virtual investor meeting with ValPro Capital on July 9, 2026. The interaction involved sharing publicly available information, with no Unpublished Price Sensitive Information disclosed. The disclosure was made under Regulation 30 of the SEBI Listing Obligations Regulations.

powered bylight_fuzz_icon
44888093

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare officials interacted with ValPro Capital during a virtual investor meeting held on July 9, 2026, at 05:00 P.M. IST. The company confirmed that only publicly available information was shared during the session and no Unpublished Price Sensitive Information (UPSI) was discussed.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This meeting follows an earlier intimation dated July 6, 2026, regarding the scheduled interaction.

Date Particulars of Investor Time Type of Meeting
Thursday, July 9, 2026 ValPro Capital 05:00 P.M. Virtual

The company requested the exchange to take the outcome of the meeting on record.

Historical Stock Returns for Amanta Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.97%+5.55%+6.86%+67.35%+21.38%+21.38%

What specific growth strategies did Amanta Healthcare highlight during the meeting?

How might ValPro Capital's interest influence Amanta Healthcare's future investor relations?

What are the potential market reactions to this investor interaction?

More News on Amanta Healthcare

1 Year Returns:+21.38%